Skip to content
sellWeak10b5-1 plan

Martha Morrell sold $265k of NPCE

Chief Medical Officer at NeuroPace Inc. 17,589 shares at an average of $15.09, traded Feb 2, 2024, filed Feb 6, 2024.

Warning score
13
Value
$265k
17,589 shares
Holdings after
77,762
-18% from before
From 52-week low
+343%
low $3.40, close $15.06
From 52-week high
0%
high $15.06, as of Feb 2, 2024

Score components

  • Role
    Officer
    +15
  • Trade size
    $265k at market
    +13
  • Share of holdings sold
    Sold 18% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NPCEOct 12, 2026 · close 13.00
Since filing Feb 6, 2024: -17.2%SPY +62.7% · excess -79.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001209191-24-002942, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 2, 2024SOpen-market sale
Common Stock10b5-1
-14,143$15.07$213k81,208Feb 6, 2024
Feb 5, 2024SOpen-market sale
Common Stock10b5-1
-3,446$15.17$52k77,762Feb 6, 2024

Related signals

Other insiders at NeuroPace Inc and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
21Weak
NPCEsell10b5-1
NeuroPace Inc
Martha Morrell
CHIEF MEDICAL OFFICER
$399k
25,000 shares
-33%
37Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$2.7M
168,136 shares
-5%
57Moderate
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$50M
5,270,845 shares
-100%
37Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$1.2M
224,138 shares
-4%
12Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$25k
4,082 shares
-0%
19Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$53k
8,598 shares
-0%
26Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$303k
46,426 shares
-1%
12Weak
NPCEsell10b5-1
NeuroPace Inc
Martha Morrell
Chief Medical Officer
$209k
13,848 shares
-13%
0Weak
NPCEsell10b5-1
NeuroPace Inc
Martha Morrell
Chief Medical Officer
$12k
828 shares
-1%
11Weak
NPCEsell10b5-1
NeuroPace Inc
Martha Morrell
Chief Medical Officer
$136k
13,402 shares
-11%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Martha Morrell sold $265k of NPCE | InsiderTell